B2B Fintech Tipalti Announces New Partnerships with Colu, Fusion Partners, & Queue Associates
U.S.-based B2B fintech
Tipalti announced on Tuesday three new strategic partnerships to further modernize financial operations for growing companies. According to Tipalti, the new partners are
Colu, a civic engagement platform,
Fusion Partners, investment development and innovation firm, and
Queue Associates, a global full-service consulting firm that is focused on providing consulting to the Microsoft Dynamics community including, but not limited to: MSFT ERP, CRM, and cloud applications.
According to Tipalti, Colu’s mission is to make cities more vibrant, connected, and inclusive. The Colu team has set out to foster communities where individuals not only feel connected to their neighbors but also where they are invested in the success of the people living around them. Colu partners with municipalities to create custom apps that encourage residents to shop locally.
Provider of SaaS for Financial Institutions Fininbox Doubled Revenue in 2020
March 11th, 2021. According to AntonZujev, Head of Business Developmentand Sales at Fininbox, the doublingof revenue even during the pandemic .
BuildStream launches investment round on Republic
YC Funded BuildStream LaunchesInvestment Campaign for Supply ChainQuality Inspection Marketplace App,Raising $1M From Users and the Crowd.NEW YORK, Feb 21, 2021 .
Durham-based ProcessMaker raises $45 million in Series A Funding
Durham-based ProcessMaker isannouncing today that it has closed$45 million in Series A funding fromAldrich Capital Partners. Thefinancing marks the first outside .
Veteran Reg A+ broker-dealer Dalmore Group surpasses 70 Reg A+ offerings in the past 12 months, including some of the most successful Reg A+ offerings in history
Provider of SaaS for Financial Institutions Fininbox Doubled Revenue in 2020
March 11th, 2021. According to AntonZujev, Head of Business Developmentand Sales at Fininbox, the doublingof revenue even during the pandemic .
BuildStream launches investment round on Republic
YC Funded BuildStream LaunchesInvestment Campaign for Supply ChainQuality Inspection Marketplace App,Raising $1M From Users and the Crowd.NEW YORK, Feb 21, 2021 .
Durham-based ProcessMaker raises $45 million in Series A Funding
Durham-based ProcessMaker isannouncing today that it has closed$45 million in Series A funding fromAldrich Capital Partners. Thefinancing marks the first outside .
Veteran Reg A+ broker-dealer Dalmore Group surpasses 70 Reg A+ offerings in the past 12 months, including some of the most successful Reg A+ offerings in history
CHOP Researchers Find NTRK Fusions More Common than Expected in Pediatric Tumors Study highlights wide range of pediatric cancers in which NTRK fusions are more likely to occur, which could help prioritize testing for targeted treatment with FDA-approved TRK inhibitors
News provided by
Share this article
Share this article
PHILADELPHIA, Jan. 15, 2021 /PRNewswire/ In a large study of pediatric cancer patients, researchers from Children s Hospital of Philadelphia (CHOP) have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors. The researchers found that NTRK fusions are more common in pediatric tumors and also involve a wider range of tumors than adult cancers, information that could help prioritize screening for NTRK fusions in pediatric cancer patients who might benefit from treatment with TRK inhibit